The proposal would provide Commonwealth subsidies for insulin pumps for all Australians living with type 1 diabetes, with 6 options, from 1 July 2025.

• Option 1: Fully subsidise Medtronic, AMSL Tandem, YpsoPump and Omnipod DASH insulin pumps for all Australians living with type 1 diabetes.
• Option 2: Partially subsidise (50%) Medtronic, AMSL Tandem, YpsoPump and Omnipod DASH insulin pumps for all Australians living with type 1 diabetes.
• Option 3: Fully subsidise the Medtronic insulin pump only for all Australians living with type 1 diabetes.
• Option 4: Fully subsidise the AMSL Tandem insulin pump only for all Australians living with type 1 diabetes.
• Option 5: Fully subsidise the Ypsomed insulin pump only for all Australians living with type 1 diabetes.
• Option 6: Fully subsidise the Omnipod DASH insulin pump only for all Australians living with type 1 diabetes.

The request also sought distributional analysis of the impact of providing Commonwealth subsidies for insulin pumps under each option.